Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. PATH
PATH logo

PATH Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy UiPath Inc (PATH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
11.870
1 Day change
2.37%
52 Week Range
19.840
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

UiPath Inc (PATH) is not a strong buy for a beginner investor with a long-term horizon at this moment. The stock is currently facing bearish technical indicators, declining pre-market price, and mixed sentiment from analysts. While the company has shown revenue growth, its profitability metrics have significantly deteriorated, and there are no strong positive catalysts or proprietary trading signals to suggest an immediate entry point. A hold strategy is recommended until more favorable conditions emerge.

Technical Analysis

The stock's technical indicators are bearish. The MACD is positive and expanding, suggesting some momentum, but the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), indicating a downward trend. RSI is neutral at 68.263. Key resistance levels are at R1: 11.541 and R2: 12.092, with support at S1: 9.757 and S2: 9.206. The pre-market price of $11.3165 is below R1, showing weakness.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
6

Positive Catalysts

  • UiPath is integrating generative AI with robotic process automation, which could enhance its back-office workflows and position it for future AI-driven growth. Revenue increased by 15.92% YoY in Q3 2026, and gross margin improved slightly to 83.26%.

Neutral/Negative Catalysts

  • Pre-market price is down by -2.02%, reflecting negative sentiment. Analysts have recently lowered price targets, citing concerns about software sector sentiment and AI monetization challenges. Net income and EPS have plummeted significantly (-1966.16% and -1950.00% YoY, respectively). No recent congress trading data or hedge fund activity indicates a lack of strong institutional interest.

Financial Performance

In Q3 2026, UiPath's revenue grew by 15.92% YoY to $411.1M, but net income fell drastically by -1966.16% YoY to $198.8M. EPS also dropped significantly by -1950.00% YoY to 0.37. Gross margin improved slightly to 83.26%, up 1.51% YoY. While revenue growth is positive, the sharp decline in profitability is a major concern.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have a mixed view on PATH. RBC Capital recently lowered its price target from $17 to $14 and maintained a Sector Perform rating, citing concerns about AI monetization and broader software sector sentiment. Earlier, RBC and Morgan Stanley had raised price targets following strong earnings, but the overall sentiment has turned cautious due to recent market conditions.

Wall Street analysts forecast PATH stock price to rise
18 Analyst Rating
Wall Street analysts forecast PATH stock price to rise
2 Buy
15 Hold
1 Sell
Hold
Current: 11.590
sliders
Low
14
Averages
16.54
High
19
Current: 11.590
sliders
Low
14
Averages
16.54
High
19
RBC Capital
Sector Perform
downgrade
$17 -> $14
AI Analysis
2026-02-11
Reason
RBC Capital
Price Target
$17 -> $14
AI Analysis
2026-02-11
downgrade
Sector Perform
Reason
RBC Capital lowered the firm's price target on UiPath to $14 from $17 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q4 earnings in Software. Given negative investor sentiment towards software, the firm prefers ideas that have a cleaner path to AI monetization and market consolidation within cyber and data/infrastructure ideas as well as vertical SaaS, the analyst tells investors in a research note. RBC adds it is updating it price target models to reflect significant year-to-date multiple compression.
RBC Capital
Sector Perform
downgrade
$19 -> $17
2026-01-05
Reason
RBC Capital
Price Target
$19 -> $17
2026-01-05
downgrade
Sector Perform
Reason
RBC Capital lowered the firm's price target on UiPath to $17 from $19 and keeps a Sector Perform rating on the shares. 2026 is likely to be a year when AI tailwinds become more evident for companies well positioned for enterprise AI adoption, while less prepared peers may remain pressured by the "AI is the death of software" narrative, the analyst tells investors in a research note. Enterprise spending appears to be stabilizing and improving in select areas, with GenAI driving innovation even as management teams remain conservative in early 2026 guidance, the firm says.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PATH
Unlock Now

People Also Watch